Literature DB >> 17615687

Nanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathways.

Xiao-Bo Wang1, Hui-Yuan Gao, Bai-Ling Hou, Jian Huang, Rong-Gang Xi, Li-Jun Wu.   

Abstract

Nanoparticle realgar powders (NRP) inhibited U937 cell growth in a time and dose-dependent manner. U937 cells treated with NRP showed typical characteristics of apoptosis including the morphological changes and DNA fragmentation. Caspase family inhibitor (z-VAD-fmk), caspase-8, -9 inhibitor (z-IETD-fmk, Ac-LEHD-CHO, respectively) and caspase-3 inhibitor (z-DEVD-fmk) partially prevented NRP -induced apoptosis. Moreover, the classical substrates of caspase-3, poly-ADP ribose polymerase (PARP) was degraded after U937 cells treatment with NRP. In addition, NRP increased the ratio of Bax/Bcl-2 protein expression. Although p38 inhibitor (SB203580) and ERK inhibitor (PD98059) failed to block cell death, JNK inhibitor (SP600125) had marked inhibitory effects on NRP -induced apoptosis. Furthermore, the phosphorylation of JNK was up-regulated, suggesting that JNK was responsible for NRP -induced apoptosis in U937 cells. These results suggested that the caspase, mitochondria and MAPK signal pathways were involved in NRP-induced U937 apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17615687     DOI: 10.1007/bf02977662

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  14 in total

1.  Ethylacetate extract from Tetrastigma hemsleyanum induces apoptosis via the mitochondrial caspase-dependent intrinsic pathway in HepG2 cells.

Authors:  Xin Peng; Yuan-Yuan Zhang; Jin Wang; Qingyong Ji
Journal:  Tumour Biol       Date:  2015-08-09

2.  Tetra-arsenic tetra-sulfide induces cell cycle arrest and apoptosis in retinoic acid-resistant acute promyelocytic leukemia cells.

Authors:  Yuan Wang; Peng-Cheng He; Jun Qi; Yan-Feng Liu; Mei Zhang
Journal:  Biomed Rep       Date:  2015-05-21

Review 3.  Cytotoxicological pathways induced after nanoparticle exposure: studies of oxidative stress at the 'nano-bio' interface.

Authors:  Henry Lujan; Christie M Sayes
Journal:  Toxicol Res (Camb)       Date:  2017-07-13       Impact factor: 3.524

Review 4.  Mitochondrial Function in Allergic Disease.

Authors:  Divyaanka Iyer; Navya Mishra; Anurag Agrawal
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

5.  Acid Water-ground Nano-realgar Is Superior to Crude Realgar in Promoting Apoptosis of MCF-7 Breast Cancer Cells.

Authors:  Juan Xi; Jia-Hui Fang; Xiao-Mei Xiong; Chun Gui; Yu-Xue Wang; Xiu-Qiao Zhang
Journal:  Curr Med Sci       Date:  2022-07-05

6.  Tetra-arsenic tetra-sulfide (As4S 4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.

Authors:  Yanfeng Liu; Pengcheng He; Feng Liu; Naicen Zhou; Xiaoyan Cheng; Lili Shi; Huachao Zhu; Jing Zhao; Yuan Wang; Mei Zhang
Journal:  Tumour Biol       Date:  2014-01-16

Review 7.  Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).

Authors:  Peter Baláž; Ján Sedlák
Journal:  Toxins (Basel)       Date:  2010-06-21       Impact factor: 4.546

8.  Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells.

Authors:  Yan-li An; Fang Nie; Zi-yu Wang; Dong-sheng Zhang
Journal:  Int J Nanomedicine       Date:  2011-12-06

9.  Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.

Authors:  Yuwang Tian; Yanfeng Liu; Pengcheng He; Feng Liu; Naicen Zhou; Xiaoyan Cheng; Lili Shi; Huachao Zhu; Jing Zhao; Yuan Wang; Mei Zhang
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

10.  Enhanced antitumor activity of realgar mediated by milling it to nanosize.

Authors:  Ye Tian; Xiaobo Wang; Ronggang Xi; Weisan Pan; Shuang Jiang; Zhao Li; Yu Zhao; Guanghui Gao; Dan Liu
Journal:  Int J Nanomedicine       Date:  2014-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.